Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
Nicolau
David P
DP
Center for Anti-infective Research & Development, Hartford Hospital, Connecticut, USA.
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D016993:Chlamydophila pneumoniae / Q000187:drug effects; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007875:Legionella / Q000187:drug effects; D001936:Moraxella catarrhalis / Q000187:drug effects; D009177:Mycoplasma pneumoniae / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents